New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Surrey scientists develop a non-invasive diagnostic test for oral cancer

Surrey scientists develop a non-invasive diagnostic test for oral cancer

A non-invasive diagnostic test for oral cancer has been developed by researchers at the University of Surrey.Surrey scientists have developed a proof-of-concept test called PANDORA that was shown to b
World medicine November 25,2023
Surrey scientists develop a non-invasive diagnostic test for oral cancer

Surrey scientists develop a non-invasive diagnostic test for oral cancer

A non-invasive diagnostic test for oral cancer has been developed by researchers at the University of Surrey.Surrey scientists have developed a proof-of-concept test called PANDORA that was shown to b
World medicine November 25,2023
Researchers uncover new clue as to how "whole genome doubling" drives cancer

Researchers uncover new clue as to how "whole genome doubling" drives cancer

A single cell contains 2-3 meters of DNA, meaning that the only way to store it is to package it into tight coils. The solution is chromatin: a complex of DNA wrapped around proteins called histones.
World medicine November 25,2023
Researchers uncover new clue as to how "whole genome doubling" drives cancer

Researchers uncover new clue as to how "whole genome doubling" drives cancer

A single cell contains 2-3 meters of DNA, meaning that the only way to store it is to package it into tight coils. The solution is chromatin: a complex of DNA wrapped around proteins called histones.
World medicine November 25,2023
Using antagonistic drug combinations for selective killing of resistant cancer cells

Using antagonistic drug combinations for selective killing of resistant cancer cells

A new review paper was published inOncotarget'sVolume 14 on March 11, 2023, entitled, "Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer
World medicine November 25,2023
Using antagonistic drug combinations for selective killing of resistant cancer cells

Using antagonistic drug combinations for selective killing of resistant cancer cells

A new review paper was published inOncotarget'sVolume 14 on March 11, 2023, entitled, "Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer
World medicine November 25,2023
Is Saw Palmetto as Good as Propecia?

Is Saw Palmetto as Good as Propecia?

May 1523:482016 by Kevin RandsPrint TYou’ve heard that Saw Palmetto is a “natural” and “safe” and “effective” alternative to Propecia. We’re not so sure that is the case, and h
World medicine November 25,2023
Is Saw Palmetto as Good as Propecia?

Is Saw Palmetto as Good as Propecia?

May 1523:482016 by Kevin RandsPrint TYou’ve heard that Saw Palmetto is a “natural” and “safe” and “effective” alternative to Propecia. We’re not so sure that is the case, and h
World medicine November 25,2023
Research funding could advance cancer treatment

Research funding could advance cancer treatment

Cancer treatment could be advanced as a result of research funding awarded to the University of the West of Scotland (UWS).UWS School of Computing Engineering and Physical Sciences are developing brea
World medicine November 25,2023
Research funding could advance cancer treatment

Research funding could advance cancer treatment

Cancer treatment could be advanced as a result of research funding awarded to the University of the West of Scotland (UWS).UWS School of Computing Engineering and Physical Sciences are developing brea
World medicine November 25,2023
Drug combination may reduce the risk of prostate cancer progression, death

Drug combination may reduce the risk of prostate cancer progression, death

TALAPRO-2, a study led by Neeraj Agarwal, MD, FASCO, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.Agarwal, Presidential Endo
World medicine November 25,2023
Drug combination may reduce the risk of prostate cancer progression, death

Drug combination may reduce the risk of prostate cancer progression, death

TALAPRO-2, a study led by Neeraj Agarwal, MD, FASCO, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.Agarwal, Presidential Endo
World medicine November 25,2023
CRISPR screens reveal genetic determinants of PARP inhibition in prostate cancer

CRISPR screens reveal genetic determinants of PARP inhibition in prostate cancer

Prostate cancer tumors harboringBRCA1/2mutations are exceptionally sensitive to PARP inhibitors, while genomic alterations in other DNA damage response (DDR) genes are less responsive. To
World medicine November 25,2023
CRISPR screens reveal genetic determinants of PARP inhibition in prostate cancer

CRISPR screens reveal genetic determinants of PARP inhibition in prostate cancer

Prostate cancer tumors harboringBRCA1/2mutations are exceptionally sensitive to PARP inhibitors, while genomic alterations in other DNA damage response (DDR) genes are less responsive. To
World medicine November 25,2023
Redoubling efforts to highlight the importance of colorectal cancer screening

Redoubling efforts to highlight the importance of colorectal cancer screening

With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine's Section of Digestive Diseases are redoubling their efforts to spread the wo
World medicine November 25,2023
Redoubling efforts to highlight the importance of colorectal cancer screening

Redoubling efforts to highlight the importance of colorectal cancer screening

With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine's Section of Digestive Diseases are redoubling their efforts to spread the wo
World medicine November 25,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com